SCHEMBL7974404

SCHEMBL7974404

CCOc1cccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.49
ALDH1A1 P00352 4/20 0.49
HPGD P15428 3/20 0.49
GAA P10253 1/20 0.48
KMT2A Q03164 2/20 0.48
XBP1 P17861 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TP53 P04637 2/20 0.43
GUSB P08236 1/20 0.43
ICMT O60725 1/20 0.42
BRD4 O60885 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
RAB9A P51151 1/20 0.42
NFKB2 Q00653 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985391 0.91 HPGD (0.47) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
Morpholine SCHEMBL7988796 0.91 KMT2A (0.52) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7974583 0.91 GAA (0.59) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7984451 0.90 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7974476 0.89 GUSB (0.56) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7985844 0.86 GAA (0.52) ALDH1A1HPGDGAATP53KDM4E
SCHEMBL7988590 0.85 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7975265 0.85 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7974016 0.85 GAA (0.56) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7985355 0.85 GAA (0.56) SMN1; SMN2ALDH1A1HPGDGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed